Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system

被引:531
作者
Veldman, CM [1 ]
Cantorna, MT [1 ]
DeLuca, HF [1 ]
机构
[1] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA
关键词
D O I
10.1006/abbi.1999.1605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In addition to its role in calcium and skeletal homeostasis, there is increasing evidence that the hormonal form of vitamin D-,D- 1,25-dihydroxyvitamin D-3, appears to serve as a modulator of the immune system. We have determined the level of the 1,25-dihydroxyvitamin D-3 receptor (VDR) in resting and activated lymphocytes by immuno- and ligand-binding assays. As expected from previous work, the total T lymphocyte population contains VDR whose levels are increased when activated and treated with 1,25-dihydroxyvitamin D-3. Surprisingly, the highest concentrations of VDR are found in CD8 lymphocytes, although significant amounts are also present in CD4 lymphocytes. Furthermore, B lymphocytes do not contain detectable amounts of VDR. Cells of the monocyte/macrophage lineage possess small amounts of VDR that are not affected by activation but are increased by treatment with 1,25-dihydroxyvitamin D-3. These results suggest that CD8 lymphocytes may be a major site of 1,25-dihydroxyitamin D-3 action, while B lymphocytes are likely not directly regulated by 1,25-dihydroxyvitamin D-3. (C) Academic Press.
引用
收藏
页码:334 / 338
页数:5
相关论文
共 36 条
[1]   DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS INDUCED BY 1-ALPHA,25-DIHYDROXYVITAMIN-D3 [J].
ABE, E ;
MIYAURA, C ;
SAKAGAMI, H ;
TAKEDA, M ;
KONNO, K ;
YAMAZAKI, T ;
YOSHIKI, S ;
SUDA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :4990-4994
[2]   SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN-D3 IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRESENCE IN MONOCYTES AND INDUCTION IN LYMPHOCYTES-T FOLLOWING ACTIVATION [J].
BHALLA, AK ;
AMENTO, EP ;
CLEMENS, TL ;
HOLICK, MF ;
KRANE, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (06) :1308-1310
[3]   EXPRESSION OF 1,25(OH)2D3 RECEPTORS ON ALVEOLAR LYMPHOCYTES FROM PATIENTS WITH PULMONARY GRANULOMATOUS DISEASES [J].
BIYOUDIVOUENZE, R ;
CADRANEL, J ;
VALEYRE, D ;
MILLERON, B ;
HANCE, AJ ;
SOLER, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (06) :1376-1380
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   1,25-dihydroxyvitamin D-3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis [J].
Cantorna, MT ;
Hayes, CE ;
DeLuca, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7861-7864
[6]   1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis [J].
Cantorna, MT ;
Hayes, CE ;
DeLuca, HF .
JOURNAL OF NUTRITION, 1998, 128 (01) :68-72
[7]  
CHEN WC, 1987, CLIN EXP IMMUNOL, V69, P639
[8]   MONOCLONAL-ANTIBODIES TO THE PORCINE INTESTINAL RECEPTOR FOR 1,25-DIHYDROXYVITAMIN D3 - INTERACTION WITH DISTINCT RECEPTOR DOMAINS [J].
DAME, MC ;
PIERCE, EA ;
PRAHL, JM ;
HAYES, CE ;
DELUCA, HF .
BIOCHEMISTRY, 1986, 25 (16) :4523-4534
[9]  
Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89
[10]   VITAMIN-D - RECENT ADVANCES [J].
DELUCA, HF ;
SCHNOES, HK .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :411-439